Gennova Biopharmaceuticals expands CEPI partnership for Nipah virus saRNA vaccine development
Gennova secures $13.38 million from CEPI to advance self-amplifying mRNA vaccine for Nipah virus
Recover your password.
A password will be e-mailed to you.